Fourteen mutations in TBX5 that cause Holt–Oram syndrome. (A) TBX5 genomic structure (our unpublished data and refs. and ) is shown with approximate intron sizes. Exons 1–9 are shown with vertical bars. Exons 1a, 1b, or 1c are alternatively spliced as the first exon of the TBX5 cDNA. Alternative splicing of the 3′ region of the gene accounts for the variable addition of exon 9. Arrows indicate the translocation t(5;12)(q15;q24) found in the family IIa proband [designated t(5;12)], which disrupts TBX5 in intron 1a and the location of intron 2 acceptor site (AS) mutations Int2ASC−2A and Int2ASG+1C. Acceptor site residues were numbered from the splice site with the conserved G residue designated as +1. (B) Schematic representation of TBX5 cDNA (GenBank accession nos. U80987 and U89353) illustrating the largest of the alternatively spliced transcripts. Untranslated sequence (dark shading), exons 1–9 (numbered boxes), and locations of amino acids 1 and 517 are indicated. Codons (gray shading) that encode the T-box DNA binding domain [residues 56–238 (exons 3–7)] were defined by homology to other T-box gene family members. TBX5 mutations that are predicted to truncate TBX5 are shown above; missense mutations are indicated below (bold, italics). Mutations are designated by the name and number of the first substituted amino acid residue: Δ, deletion; Ins, insertion. FSter indicates frameshift mutations with resultant premature stop codons; ter indicates nonsense mutation. Mutations Glu69ter, Arg237Gln, InsAsn198FSter, Arg279ter, and InsSer387FSter have been described (, ). Mutation Ser196ter, reported here, was also previously observed in an unrelated family ().